{"id":11305,"date":"2025-07-27T01:56:41","date_gmt":"2025-07-26T23:56:41","guid":{"rendered":"https:\/\/valintermed.com\/?p=11305"},"modified":"2025-07-27T01:56:41","modified_gmt":"2025-07-26T23:56:41","slug":"aldosteronizm-poddayuschiysya-lecheniyu-glyukokortikoidami","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/aldosteronism-induced-by-glyukokortikoid-therapy\/","title":{"rendered":"Aldosteronism responsive to glucocorticoid treatment"},"content":{"rendered":"
<\/div>\n

Aldosteronism is an endocrine disorder caused by the hypersecretion of aldosterone, a mineralocorticoid hormone produced by the adrenal cortex. Elevated aldosterone levels lead to sodium and water retention in the body, which in turn causes hypertension and hypokalemia. This condition can be secondary, associated with other pathological processes such as Conn's syndrome or adrenocortical adenoma, or primary, when hormone secretion is not controlled by the renin-angiotensin system. Treatment of aldosteronism involves the use of glucocorticoids, which helps prevent negative consequences of the disease, such as cardiovascular complications and renal failure.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n